C Corpechot
Overview
Explore the profile of C Corpechot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1535
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salin G, Corpechot C, Ouazana S, Dong C, Becq A, Lemoinne S, et al.
Clin Res Hepatol Gastroenterol
. 2024 Mar;
48(5):102324.
PMID: 38527568
Background And Objective: LPAC (low phospholipid-associated cholelithiasis) syndrome is a rare genetic form of cholelithiasis. ERCP (endoscopic retrograde cholangiopancreatography) is often used to remove gallstones in the bile duct. No...
2.
Hegade V, Krawczyk M, Kremer A, Kuczka J, Gaouar F, Kuiper E, et al.
Aliment Pharmacol Ther
. 2015 Nov;
43(2):294-302.
PMID: 26526892
Background: Pruritus is a common symptom associated with cholestatic liver diseases. To date only small single centre case series have suggested efficacy of nasobiliary drainage in relieving cholestatic pruritus. Aim:...
3.
Corpechot C, Chazouilleres O
Rev Med Interne
. 2010 Aug;
31(9):606-14.
PMID: 20674103
Autoimmune hepatitis is a disorder of unknown aetiology that occurs in children and adults of all ages with a female predominance. The spectrum of presentation is wide, ranging from no...
4.
Rabahi N, Chretien Y, Gaouar F, Wendum D, Serfaty L, Chazouilleres O, et al.
Gastroenterol Clin Biol
. 2010 Apr;
34(4-5):283-7.
PMID: 20417047
Background/aims: To assess the benefit of the UDCA-budesonide combination in association with mycophenolate mofetil (MMF) in patients with primary biliary cirrhosis (PBC) at high risk of developing cirrhosis or liver...
5.
Ferroir J, Corpechot C, Freudenreich A, Khalil A
Rev Neurol (Paris)
. 2009 Feb;
165(10):828-30.
PMID: 19217129
Introduction: Neurological complications of metronidazole are rare, predominantly peripheral neuropathies, especially in patients on a long-term high-dose regimen. Cerebellar syndrome or seizures are less frequently reported. The concomitant occurrence of...
6.
Abenavoli L, Corpechot C, Poupon R
Can J Gastroenterol
. 2007 Dec;
21(12):839-42.
PMID: 18080057
A common characteristic of all chronic liver diseases is the occurrence and progression of fibrosis toward cirrhosis. Consequently, liver fibrosis assessment plays an important role in hepatology. Besides its importance...
7.
Corpechot C, El Naggar A, Poupon R
Hepatology
. 2006 Jul;
44(2):513-4.
PMID: 16871581
No abstract available.
8.
Corpechot C, Benlian P, Barbu V, Chazouilleres O, Poupon R, Poupon R
J Hepatol
. 2001 Oct;
35(3):324-8.
PMID: 11592592
Background/aims: To determine whether the apolipoprotein E (apo-E) polymorphism is associated with the risk of primary biliary cirrhosis (PBC), the severity of the disease and its response to ursodeoxycholic acid...
9.
Corpechot C, Barbu V, Chazouilleres O, Poupon R
J Hepatol
. 2000 Nov;
33(5):696-700.
PMID: 11097475
Background/aims: Recent studies have suggested a role of fetal microchimerism in the pathogenesis of scleroderma. The present study investigated the potential role of fetal microchimerism in primary biliary cirrhosis (PBC),...
10.
Corpechot C, Carrat F, Bonnand A, Poupon R, Poupon R
Hepatology
. 2000 Nov;
32(6):1196-9.
PMID: 11093724
Ursodeoxycholic acid (UDCA) is the only approved treatment for primary biliary cirrhosis (PBC). However, the benefit from UDCA therapy on the progression of PBC from its early stage towards extensive...